MADISON (WKOW) -- The Wisconsin Alumni Research Foundation (WARF) announced the signing of an exclusive licensing agreement with Echometrix on Monday.
WARF is a private, non-profit patent and licensing organization for the University of Wisconsin-Madison. Echometrix is a developer of ultrasound technology.
The new agreement will give Echometrix the rights to make, use and sell ultrasound software and devices based on its innovative technology in the United States, Europe and Japan.
"The addition of the intellectual property developed by my co-founders, Dr. Hirohito Kobayashi and Dr. Ray Vanderby at the University of Wisconsin-Madison, will create a sustainable competitive advantage in the underpenetrated and growing musculoskeletal ultrasound market," says Barbara Israel, company co-founder and chief executive officer. "We also believe that this is the beginning of an important research and development collaboration between Echometrix and the Vanderby lab."
WARF believes that Echometrix's technology has the potential to positively impact patient health.
"The technology will offer orthopedics, sports medicine, physical therapy and rheumatology practitioners a new tool to quantitatively assess the function of ligaments and tendons, which could both improve patient outcomes and lower the cost of assessing musculoskeletal injuries," Heim says.
Echometrix's technology works to improve the speed, convenience and ability to evaluate musculoskeletal conditions at a lower cost than current methods. The company's ultrasound technology is able to uniquely assess the functional status of soft tissues and to identify conditions like stretched ligaments, torn tendons, micro tears, and tissue inflammation. It can also prove valuable in assessing common conditions like carpal tunnel syndrome and damaged rotator cuffs.
For more information about WARF, click here.
For more information about Echometrix, click here.